These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 22072613

  • 1. RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism.
    Na W, Peng G, Jianping Z, Yanzhong C, Shengjiang G, Li C.
    Toxicol Ind Health; 2012 Oct; 28(9):831-9. PubMed ID: 22072613
    [Abstract] [Full Text] [Related]

  • 2. Preventive effects of fasudil on adriamycin-induced cardiomyopathy: possible involvement of inhibition of RhoA/ROCK pathway.
    Wang N, Guan P, Zhang JP, Chang YZ, Gu LJ, Hao FK, Shi ZH, Wang FY, Chu L.
    Food Chem Toxicol; 2011 Nov; 49(11):2975-82. PubMed ID: 21803115
    [Abstract] [Full Text] [Related]

  • 3. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
    Wang N, Guan P, Zhang JP, Li YQ, Chang YZ, Shi ZH, Wang FY, Chu L.
    J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
    [Abstract] [Full Text] [Related]

  • 4. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
    Li WJ, Park K, Paick JS, Kim SW.
    J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
    [Abstract] [Full Text] [Related]

  • 5. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F, Xia W, Li A, Zhao C, Sun R.
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [Abstract] [Full Text] [Related]

  • 6. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R, Hata Y, Nakao S, Kita T, Miura M, Kawahara S, Zandi S, Almulki L, Tayyari F, Shimokawa H, Hafezi-Moghadam A, Ishibashi T.
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [Abstract] [Full Text] [Related]

  • 7. Rho-kinase inhibition reverses impaired Ca2+ handling and associated left ventricular dysfunction in pressure overload-induced cardiac hypertrophy.
    Olgar Y, Celen MC, Yamasan BE, Ozturk N, Turan B, Ozdemir S.
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [Abstract] [Full Text] [Related]

  • 8. Shen'ge powder decreases the cardiomyocyte hypertrophy in chronic heart failure by activating the Rho protein/Rho-associated coiledcoil forming protein kinase signaling pathway.
    Yan X, Jiao K, Song X.
    J Cell Biochem; 2019 Mar; 120(3):3038-3045. PubMed ID: 30474257
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro.
    Xiang C, Yan Y, Zhang D.
    J Pharmacol Sci; 2021 Jan; 145(1):6-15. PubMed ID: 33357780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fasudil alleviates acetaminophen-induced liver injury via targeting Rhoa/ROCK signal pathway.
    Ren X, Meng T, Ren X, Li X, Lu L.
    J Toxicol Sci; 2021 Jan; 46(6):255-262. PubMed ID: 34078832
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.
    Guan SJ, Ma ZH, Wu YL, Zhang JP, Liang F, Weiss JW, Guo QY, Wang JY, Ji ES, Chu L.
    Food Chem Toxicol; 2012 Jun; 50(6):1874-82. PubMed ID: 22429817
    [Abstract] [Full Text] [Related]

  • 16. Rho Kinase Inhibition by Fasudil Attenuates Adriamycin-Induced Chronic Heart Injury.
    Yan Y, Xiang C, Yang Z, Miao D, Zhang D.
    Cardiovasc Toxicol; 2020 Aug; 20(4):351-360. PubMed ID: 31894538
    [Abstract] [Full Text] [Related]

  • 17. [The expression of Rho/Rho kinase of cardiac muscle in heart failure rats caused by pressure overload and the intervention of fasudil].
    Zhang M, Qu C, Zeng DY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):73-6. PubMed ID: 15924788
    [Abstract] [Full Text] [Related]

  • 18. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
    Gao H, Hou F, Dong R, Wang Z, Zhao C, Tang W, Wu Y.
    Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
    [Abstract] [Full Text] [Related]

  • 19. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
    Zhuang R, Wu J, Lin F, Han L, Liang X, Meng Q, Jiang Y, Wang Z, Yue A, Gu Y, Fan H, Zhou X, Liu Z.
    Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
    [Abstract] [Full Text] [Related]

  • 20. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY, Dun JN, Miao QF, Zhang YJ.
    Pharmacology; 2009 Sep; 83(2):67-79. PubMed ID: 19052484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.